Arcus Biosciences Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides a Pipeline Update
Go back to Arcus Biosciences Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides a Pipeline Update| (NYSE: RCUS) | Delayed: 28.18 +0.95 (3.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.23 | 52 Week High | $ | |||
| Open | $26.72 | 52 Week Low | $ | |||
| Day High | $28.27 | P/E | N/A | |||
| Day Low | $26.72 | EPS | $ | |||
| Volume | 2,341,907 | |||||

